• Mashup Score: 0

    Tailored management for high-risk locoregional disease, with more effective immunotherapy combinations are key areas

    Tweet Tweets with this article
    • #ESMO23:After recent advancements in #nasopharingeal #CancerManagement, due to #immunotherapy and an effective #biomarker, what’s next for #NPC? Anthony Chan: treating patients w/ post-treatment residual #EBV DNA is an issue #ESMODailyReporter 👉 https://t.co/xNMCMhmQk6 https://t.co/6u2uzcmCwL

  • Mashup Score: 0

    In a Taiwanese study reported in the Journal of Clinical Oncology, Lou et al compared two methods of Epstein-Barr Virus (EBV)-screening to identify nasopharyngeal carcinoma. Blood samples were obtained from 819 incident Taiwanese nasopharyngeal carcinoma cases (including 213 cases of early-stage disease) diagnosed between 2010 to 2014, as well as from 1,768 controls matched for age and sex from the same region. EBV assessments consisted of an EBV antibody score using immunoglobulin A antibodies measured

    Tweet Tweets with this article
    • EBV-Based Screening Methods for Identifying Nasopharyngeal Carcinoma https://t.co/oHdEhUXuQz #EBV #screening #hncsm #headneckcancer #oncology

  • Mashup Score: 1

    Fatigue is a common reason that patients seek medical care. Only a fraction of these patients meet criteria for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). To determine if ME/CFS is just a more extreme form of fatigue, or a qualitatively different condition, we assessed whether risk factors for ME/CFS and for Severe Fatigue were similar. An email questionnaire that inquired about…

    Tweet Tweets with this article
    • Different risk factors distinguish myalgic encephalomyelitis/#chronicfatigue syndrome from severe #fatigue https://t.co/tbCQUk2Qkd #CFS #mono #EBV Risk factors differ between severe fatigue and #MECFS, potentially suggesting a different underlying pathophysiology.